Bristol-Myers Squibb confirmed on Wednesday that it would cut nearly 10% of its 43,000-member workforce. The drugmaker also announced plans to sell or close half of its 27 manufacturing plants across the globe, outsource some of its manufacturing and shrink its portfolio of 500 products by 60%.